Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 3, 2007, Pages 976-981

  Dekkers, O M ^a   Biermasz, N R ^a   Pereira, A M ^a   Roelfsema, F ^a   Van Aken, M O ^a   Voormolen, J H C ^a   Romijn, J A ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; HYDROCORTISONE; KETOCONAZOLE; LEVOTHYROXINE; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT GROWTH HORMONE; TESTOSTERONE;

ADRENALECTOMY; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CUSHING DISEASE; FEMALE; FOLLOW UP; HAZARD RATIO; HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE SYNTHESIS; HUMAN; HYPERCORTISOLISM; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; MENOPAUSAL SYNDROME; MORBIDITY; MORTALITY; NONFUNCTIONING PITUITARY ADENOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL ANALYSIS; TRANSSPHENOIDAL SURGERY; TUMOR CLASSIFICATION; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 33947513244     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2112     Document Type: Article

References (34)

1. Dekkers OM, Pereira AM, Roelfsema F, Voormolen JH, Neelis KJ, Schroijen MA, Smit JW, Romijn JA 2006 Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91:1796-1801
2. Newell-Price J, Bertagna X, Grossman AB, Nieman LK 2006 Cushing's syndrome. Lancet 367:1605-1617
3. Mancini T, Kola B, Mantero F, Boscaro M, Arnaldi G 2004 High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. Clin Endocrinol (Oxf) 61:768-777
4. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G 1999 Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84:2664-2672
5. Faggiano A, Pivonello R, Spiezia S, De Martino MC, Filippella M, Di Somma C, Lombardi G, Colao A 2003 Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88:2527-2533
6. Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, Jonsson B 2000 Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 85:1420-1425
7. Bates AS, Bullivant B, Sheppard MC, Stewart PM 1999 Life expectancy following surgery for pituitary tumours. Clin Endocrinol (Oxf) 50:315-319
8. Brada M, Ashley S, Ford D, Traish D, Burchell L, Rajan B 2002 Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol (Oxf) 57:713-717
9. Etxabe J, Vazquez JA 1994 Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 40:479-484
10. Pikkarainen L, Sane T, Reunanen A 1999 The survival and well-being of patients treated for Cushing's syndrome. J Intern Med 245:463-468
11. Rosen T, Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336:285-288
12. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM 2001 Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425-431
13. Bulow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM 1997 Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol (Oxf) 46:75-81
14. Pereira AM, van Aken MO, van Dulken H, Schutte PJ, Biermasz NR, Smit JW, Roelfsema F, Romijn JA 2003 Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease. J Clin Endocrinol Metab 88:5858-5864
15. Biemond P, de Jong FH, Lamberts SW 1990 Continuous dexamethasone infusion for seven hours in patients with the Cushing syndrome. A superior differential diagnostic test. Ann Intern Med 112:738-742
16. Newell-Price J, Trainer P, Besser M, Grossman A 1998 The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 19:647-672
17. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ 2002 Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab 87:477-485
18. van der Klaauw AA, Pereira AM, van Thiel SW, Smit JW, Corssmit EP, Biermasz NR, Frolich M, Iranmanesh A, Veldhuis JD, Roelfsema F, Romijn JA 2006 GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion. Eur J Endocrinol 154:851-858
19. Ross DS, Daniels GH, Gouveia D 1990 The use and limitations of a chemiluminescent thyrotropin assay as a single thyroid function test in an out-patient endocrine clinic. J Clin Endocrinol Metab 71:764-769
20. Hardy J 1979 The transsphenoidal surgical approach to the pituitary. Hosp Pract 14:81-89
21. Barker FG, Klibanski A, Swearingen B 2003 Transsphenoidal surgery for pituitary tumors in the United States, 1996 -2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88:4709-4719
22. Ciric I, Ragin A, Baumgartner C, Pierce D 1997 Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery 40:225-236
23. Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS 2004 Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab 89:1613-1617
24. Biermasz NR, Dekker FW, Pereira AM, van Thiel SW, Schutte PJ, van Dulken H, Romijn JA, Roelfsema F 2004 Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. J Clin Endocrinol Metab 89:2789-2796
25. Markussis V, Beshyah SA, Fisher C, Parker KH, Nicolaides AN, Johnston DG 1997 Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults. Eur J Endocrinol 136:157-164
26. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG 1992 Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet 340:1188-1192
27. Johnston DG, Beshyah SA, Markussis V, Shahi M, Sharp PS, Foale RA, Skinner EM 1992 Metabolic changes and vascular risk factors in hypopituitarism. Horm Res 38(Suppl 1):68-72
28. Kohno H, Kuromaru R, Ueyama N, Miyako K 2001 Premature mortality and hypopituitarism. Lancet 357:1973-1974
29. Gittoes NJ, Bates AS, Tse W, Bullivant B, Sheppard MC, Clayton RN, Stewart PM 1998 Radiotherapy for non-function pituitary tumours. Clin Endocrinol (Oxf) 48:331-337
30. Lindholm J, Nielsen EH, Bjerre P, Christiansen JS, Hagen C, Juul S, Jorgensen J, Kruse A, Laurberg P, Stochholm K 2006 Hypopituitarism and mortality in pituitary adenoma. Clin Endocrinol (Oxf) 65:51-58
31. Plotz CM, Knowlton AI, Ragan C 1952 The natural history of Cushing's syndrome. Am J Med 13:597-614
32. Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kosteljanetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J 2001 Incidence and late prognosis of cushing's syndrome: a population-based study. J Clin Endocrinol Metab 86:117-123
33. Swearingen B, Biller BM, Barker 2nd FG, Katznelson L, Grinspoon S, Klibanski A, Zervas NT 1999 Long-term mortality after transsphenoidal surgery for Cushing disease. Ann Intern Med 130:821-824
34. Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, Rahl R, Lu A, Wilson CB 2004 Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. J Clin Endocrinol Metab 89:6348-6357